GRV greenvale energy ltd

5.88%

3.2¢

AMPL, I note your assessment that the Alpha project may elicit...

First 24 Last

Share
Profile

Follow
Pokerface

7,580 Posts.

2782

20/11/20

19:46

Post #: 49030292
Share

Originally posted by ampl ↑

I sympathize with your thoughts! Having said that there are a few blocks of shares which could come out but that is probably a good thing as it adds to the depth of the rally in the long run. As to your figures from your prior post, as per the May SRK report, it talked of 430,000 barrels of refined liquid petroleum [diesel], 90,000 tonnes of bitumen and 400,000 tonnes of active carbons products. If you were to refine these, which would be the expensive part, you can easily work out sales of $80 million plus. In my very rough back of the envelope calculations GRV could be mining circa 700,000 tonnes, a large quarry, of product a year with a profit of $8 to $10 million with a capital cost of say $50 million, $10 million for quarry and retort plus $40 million for refining. I therefor agree with your target price of 30 cents to 40 cents. If you were to add to this any excitement from the Georgiana Basin over the next 12 months added to the new management the future looks bright to those that wish to hold.

Expand

AMPL, I note your assessment that the Alpha project may elicit revenues of $80m/ annum.

I would point you to the Company’s website where the very interesting RRS video presentation has been uploaded.

I refer to two quotes from the MD re Alpha:

1. Activated Carbon is the real kicker
2. It’s worth hundreds of millions per annum to us

2021 should be mighty interesting for this microcap.

GRV Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 24 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.2¢		Change -0.002(5.88%)		Mkt cap ! $17.41M

Open	High	Low	Value	Volume
3.2¢	3.2¢	3.2¢	$11.01K	344.0K

Buyers (Bids)

No.	Vol.	Price($)
1	54010	3.2¢

Sellers (Offers)

Price($)	Vol.	No.
3.5¢	450000	1

View Market Depth

No.	Vol.	Price($)
1	54010	0.032
2	89304	0.031
2	150000	0.030
1	25000	0.028
3	439367	0.026

Price($)	Vol.	No.
0.035	450000	1
0.040	8000	1
0.044	60000	1
0.045	241924	2
0.050	45000	1

Last trade - 10.00am 27/06/2025 (20 minute delay)

GRV (ASX) Chart

AMPL, I note your assessment that the Alpha project may elicit...

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

AMPL, I note your assessment that the Alpha project may elicit...

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News